本實驗參考過去實驗室，研究低場核磁共振系統，使用超導量子干涉元件（SQUID, superconducting uantum interference device）和預極化（prepolarization）技術的低磁場核磁共振系統（Low-field NMR）應用至腫瘤量測上。改進接收線圈，使SNR提高20 % (量測0.5 ml去離子水)，進而讓乳房樣品能有效進行微量（0.05 g ~ 0.2 g）量測，利用縱向鬆弛時間（T1）之物理方式量測，並進行乳房組織最小量測量與縮短實驗時間，乳房組織經由實驗後量測T1數值，統計資料證實，正常組織與腫瘤組織具有統計意義，並計算辨識正常組織與腫瘤組織的靈敏性(Sensitivity)與特異性(Specificity)，具有高度的數值，同時證明使用T1量測，進行腫瘤組織檢測可行性。最後整合病理報告，核磁共振與病理報告內的細胞活化標記(Ki-67)、病理分期具有相關性。藉此能快速又有效提供可量化數值，提供醫師一種生物組織檢測方式。

In this study, a high-Tc SQUID-detected nuclear magnetic resonance spectrometer was set-up in National Taiwan University Hospital to discriminate Breast tumor. Improve Pick-up coil and let SNR increase 20 percent (measure 0.5 ml di-water). Make breast samples effective for micro-measurement (0.05 g ~ 0.2 g). Exploit physical measurements of longitudinal relaxation time（T1）to measure breast samples and then measurement of the minimum sample size of breast tissue and shortening the time of the experiment. Statistics confirmed that normal tissues and tumor tissues are statistically significant, and the sensitivity and specificity of identifying normal tissues and tumor tissues are calculated, with high numerical values, and it is proved that tumor tissue is measured using T1 measurement. For tumor discrimination, the T1 relaxation time of normal tissue and tumor tissue were demonstrated. Besides, the relation between T1 of tumor tissue and KI-67, pathology grade was established.

[1] Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, I Tocino, A B Wray Vol. 204, No. 2 (1997)
[2] Erin Brender, MD,” Frozen Section Biopsy “, 3200 JAMA, December 28, 2005—Vol 294, No. 24 (2005)
[3] H. C. Seton, D.M. Bussel, J.M.S. Hutchison, I. Nichoson, and D.J. Lurie, Phys. Med. Biol. 37, 2133 (1992).
[4] H. C. Seton, D.M. Bussel, J.M.S. Hutchison, and D.J. Lurie, IEEE Trans. Appl. Supercon. 5, 3218, (1995)
[5] H. C. Seton, D.M. Bussel, and J.M.S. Hutchison, in Proceedings of the 2nd European Conference on Applied Superconductivity, edited by D.Dew-Hughes (IOP, Bristol) 1487 (1995).
[6] H. C. Seton, J.M.S. Hutchison, in Proceedings of the Applied Superconducting Conference, Pittsburg, Pennylvania, 1996, IEEE transaction Appl. Supercon. 7, 3213 (1997).
[7] A.H. Trabesinger, R. McDermott, S.K. Lee, M. Mu1ck, J. Clarke, and A. Pines, “SQUID-Detected Liquid State NMR in Microtesla Fields “, J. Phys. Chem. A 108, 957-963 (2004).
[8] R. McDermott, S.K. Lee, B. ten Haken, A.H. Trabesinger, A. Pines, and J. Clarke, “Microtesla MRI with a superconducting quantum interference Device”, Proc. Natl. Acad. Sci. USA 101, 7857 (2004).
[9] Klaus SchlengaRicardo E. de SouzaAnnjoe Wong-FoyJohn ClarkeAlexander Pines, “NMR/MRI with hyperpolarized gas and high Tc SQUID” (1998).
[10] M.A. Espy, A.N. Matlachov, P.L. Volegov, J.C. Mosher, and R.H.Kraus Jr., ” SQUID-Based Simultaneous Detection of NMR and Biomagnetic Signals at Ultra-Low Magnetic Fields”, IEEE Trans.Appl. Supercon. 15, 635 (2005).
[11] M. Mössle, S. Busch, M. Hatridge, W. Myers, A. Pines, and J. Clarke, “SQUID-detected microtesla MRI: a new modality for tumor detection”, paper presented at 2006 Applied Superconductivity conference, Aug. 27-Sept.1, 2006, Seattle, Washington, USA.
[12] 周彥廷,”低磁場核磁共振梯度接收線圈應用於肝腫瘤組織檢驗”,碩士論文,台北:國立台灣師範大學,光電科技研究所(2014)
[13] 黃逸群,”低磁場核磁共振系統及其肝癌檢測應用”,碩士論文,台北:國立台灣師範大學,光電科技研究所(2015)
[14] 吳沛哲,” The Feasibility Study of Fruit Sweetness Detection by Using UltraLow Field NMR System”, 2015 Taiwan Association for Magnetic Technology Annual Meeting and the 27th Magnetic Science and Technology Conference will be held on June 28-30, 2015
[15] Shu-Hsien Liao and Herng-Er Horng, Hong-Chang Yang “The Production of Gradiometer as pick-up coil in Low-Field NMR and it’s application in the study of measuring of liver’s Tumor”(2014).
[16] Hong-Chang Yang,Shu-Hsien Liao, Herng-Er Horng,Shing-Ling Kuo,Hsin-Hsien Chen, and S. Y. Yang, Appl. Phys. Lett. 88, 252505 (2006)
[17] Shu-Hsien Liao and Herng-Er Horng, Hong-Chang Yang, and Shieh-Yueh Yang, “Longitudinal relaxation time detection using a high-Tc superconductive quantum interference device magnetmeter”,J. Appl. Phys. 102, 033914 (2007).
[18] A. Carrington and A.D. McLachlan, Introduction To Magnetic Resonance, Chapman and Hall, London 1967.
[19] Atta-ur-Rahman, Nuclear Magnetic Resonance, Basic Principles, Springer-Verlag, NY 1986.
[20] F. Noack, "NMR field-cycling spectroscopy: principles and applications." Progress in NMR Spectroscopy, 18171-276 (1986).
[21] Larmor J. LXIII. On the theory of the magnetic influence on spectra; and on the radiationfrom moving ions Phil Mag1897; Series 5, Vol 44 (271): 503-512. Tubridy N, McKinstry CS. Neuroradiological
[22] T.C. Farrar and E.D. Becker, Pulse And Fourier Transform NMR, Academic Press, 1971.
[23] E.O.Brigham, The Fast Fourier Transform, Prentice-Hall, Englewood Cliffs, NJ 1974.
[24] J. Gong and J.P. Hornak, "A Fast T1 Algorithm." Magn. Reson. Imaging 10:623-626 (1992).
[25] X. Li and J.P. Hornak, "T2 Calculations in MRI: Linear versus Nonlinear Methods." J. Imag. Sci. & Technol. 38:154-157 (1994).
[26] Human Tumors Detected by Nuclear Magnetic Resonance Proc. Nat. Acad. Sci. USA Vol. 71, No. 4, pp. 1471-1473, April 1974
[27] Seong-Joo Lee, Jeong Hyun Shim, Kiwoong Kim , * Seong-min Hwang, T 1 Relaxation Measurement of Ex-Vivo Breast Cancer Tissues at Ultralow Magnetic Fields(2015).
[28] In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy S H Chung, A E Cerussi, C Klifa, H M Baek, O Birgul, G Gulsen, S I Merritt, D Hsiang, and B J Tromberg1, Phys Med Biol. 2008 Dec 7; 53(23): 6713–6727.
[29] H. J. G. BLOOM AND W. W. RICHARDSON,” HISTOLOGICAL GRADING AND PROGNOSISIN BREAST CANCER” Received for publication July 29, 1957
[30] Adedayo A. Onitilo, MD, MSCR, FACP, Jessica M. Engel, MSN, FNP-BC,Robert T. Greenlee, PhD, and Bickol N. Mukesh, PhD,” Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival” Clin Med Res. 2009 Jun; 7(1-2): 4–13.